Do you remember when Amgen was a high flier?  That question sprang to mind today as Amgen announced that it was initiating a dividend.  Apparently the first for a major biotech company.  Given the fact that Amgen is among those large companies that possess a large cash hoard this news shouldn’t be surprising.  The company clearly needs to do something to get the stock moving.  A quick glance at a decade-long chart shows the stock price stuck in a rut.  These days Amgen trades more like a utility than a biotech stock.  Two points.  The first is that today’s high fliers, if they are lucky, eventually will become big, staid stocks.  Second, this highlights the continued valuation disparity between high quality large caps and small caps.  In today’s screencast a look at Amgen’s dividend debut.

Items mentioned in the above screencast:

Amgen provides earnings projections.  (WashingtonPost)

Amgen initiates a dividend.  (The Dynamic Dividend)

Amgen key stats.  (YCharts, ibid)

Daily price chart of Amgen (AMGN).  (Finviz)

This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.

The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.

References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.

Please see disclosures here.

Please see the Terms & Conditions page for a full disclaimer.